As mentioned above, PARP-1 mutation R591C, recently identified in the tumour of a PARPi-resistant patient, was found to prevent PARP-1 trapping, providing the first clinical evidence linking PARPi resistance with loss of PARP-trapping ability (234). This evidence concerns the gene PARP1 and neoplasm.